Scholarlink

<p>Precision-based percutaneous coronary intervention (PCI) integrates contemporary strategies across the pre-, intra-, and post-procedural phases to improve outcomes and minimize complications. Emerging evidence underscores the value of these strategies in reducing adverse events and improving procedural efficiency. While artificial intelligence and pharmacogenomics hold long-term promise for enhancing personalization, their clinical utility in PCI remains in the early stages of development.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Precision percutaneous coronary intervention

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年3月23日

查看全文
  • Travis M. Wilson,
  • Uzair Munaf,
  • Nafhat Shaikh,
  • Affan Rizwan,
  • Riyan Siddiqui,
  • Hafeez Ul Hassan Virk,
  • Mahboob Alam,
  • Umair Khalid,
  • Muzamil Khawaja,
  • Tanawat Attachaipanich,
  • Larisa H. Cavallari,
  • Tania Ahuja,
  • Michael G. Nanna,
  • Samin K. Sharma,
  • Lloyd W. Klein,
  • Gary S. Mintz,
  • Chayakrit Krittanawong

摘要

Precision-based percutaneous coronary intervention (PCI) integrates contemporary strategies across the pre-, intra-, and post-procedural phases to improve outcomes and minimize complications. Emerging evidence underscores the value of these strategies in reducing adverse events and improving procedural efficiency. While artificial intelligence and pharmacogenomics hold long-term promise for enhancing personalization, their clinical utility in PCI remains in the early stages of development.